Brokerages Expect Clorox Co (NYSE:CLX) to Post $1.31 Earnings Per Share

Equities research analysts predict that Clorox Co (NYSE:CLX) will report earnings per share of $1.31 for the current quarter, according to Zacks Investment Research. Three analysts have issued estimates for Clorox’s earnings, with estimates ranging from $1.25 to $1.35. Clorox posted earnings per share of $1.40 during the same quarter last year, which would suggest a negative year over year growth rate of 6.4%. The business is scheduled to announce its next quarterly earnings report on Monday, February 3rd.

On average, analysts expect that Clorox will report full year earnings of $6.16 per share for the current financial year, with EPS estimates ranging from $6.07 to $6.21. For the next year, analysts forecast that the business will post earnings of $6.41 per share, with EPS estimates ranging from $6.27 to $6.47. Zacks Investment Research’s earnings per share calculations are an average based on a survey of sell-side analysts that cover Clorox.

Clorox (NYSE:CLX) last posted its quarterly earnings data on Thursday, October 31st. The company reported $1.59 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.54 by $0.05. Clorox had a return on equity of 123.56% and a net margin of 13.20%. The company had revenue of $1.51 billion for the quarter, compared to analysts’ expectations of $1.51 billion. During the same period in the previous year, the firm posted $1.62 EPS. Clorox’s revenue was down 3.6% compared to the same quarter last year.

Several research firms recently issued reports on CLX. Barclays set a $138.00 price objective on Clorox and gave the stock a “sell” rating in a report on Friday, November 1st. Wells Fargo & Co reiterated a “hold” rating and issued a $150.00 price objective on shares of Clorox in a report on Wednesday, October 2nd. Citigroup lowered their price objective on Clorox from $167.00 to $163.00 and set a “neutral” rating on the stock in a report on Thursday, October 3rd. Zacks Investment Research upgraded Clorox from a “sell” rating to a “hold” rating and set a $175.00 target price on the stock in a report on Monday, July 29th. Finally, UBS Group lowered their target price on Clorox from $128.00 to $125.00 and set a “sell” rating on the stock in a report on Thursday, October 3rd. Five equities research analysts have rated the stock with a sell rating, eight have given a hold rating and two have assigned a buy rating to the company’s stock. Clorox has an average rating of “Hold” and an average target price of $152.00.

CLX stock opened at $147.29 on Thursday. The company has a current ratio of 0.87, a quick ratio of 0.52 and a debt-to-equity ratio of 4.69. Clorox has a 12-month low of $143.58 and a 12-month high of $167.70. The stock has a market cap of $18.57 billion, a price-to-earnings ratio of 23.31, a PEG ratio of 4.73 and a beta of 0.38. The business’s 50-day moving average is $149.57 and its 200 day moving average is $154.19.

The business also recently announced a quarterly dividend, which will be paid on Friday, November 15th. Stockholders of record on Wednesday, October 30th will be issued a dividend of $1.06 per share. This represents a $4.24 annualized dividend and a dividend yield of 2.88%. The ex-dividend date of this dividend is Tuesday, October 29th. Clorox’s dividend payout ratio is currently 67.09%.

In other news, SVP Michael R. Costello sold 3,225 shares of Clorox stock in a transaction that occurred on Wednesday, August 21st. The shares were sold at an average price of $161.34, for a total transaction of $520,321.50. Following the sale, the senior vice president now owns 29,669 shares of the company’s stock, valued at approximately $4,786,796.46. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, SVP Andrew J. Mowery sold 5,648 shares of Clorox stock in a transaction that occurred on Monday, November 4th. The shares were sold at an average price of $146.29, for a total transaction of $826,245.92. Following the sale, the senior vice president now directly owns 15,920 shares in the company, valued at approximately $2,328,936.80. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 15,870 shares of company stock worth $2,484,000. Insiders own 1.14% of the company’s stock.

Hedge funds have recently added to or reduced their stakes in the company. Asahi Life Asset Management CO. LTD. purchased a new stake in shares of Clorox during the 2nd quarter valued at approximately $340,000. Cambridge Investment Research Advisors Inc. raised its position in Clorox by 3.2% in the second quarter. Cambridge Investment Research Advisors Inc. now owns 27,406 shares of the company’s stock valued at $4,196,000 after purchasing an additional 858 shares during the period. Ontario Teachers Pension Plan Board raised its position in Clorox by 209.0% in the second quarter. Ontario Teachers Pension Plan Board now owns 37,846 shares of the company’s stock valued at $5,795,000 after purchasing an additional 25,599 shares during the period. CWM LLC raised its position in Clorox by 75.6% in the second quarter. CWM LLC now owns 92,127 shares of the company’s stock valued at $14,106,000 after purchasing an additional 39,668 shares during the period. Finally, Charles Schwab Investment Management Inc. raised its position in Clorox by 4.2% in the second quarter. Charles Schwab Investment Management Inc. now owns 969,843 shares of the company’s stock valued at $148,493,000 after purchasing an additional 39,390 shares during the period. 78.56% of the stock is currently owned by hedge funds and other institutional investors.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Cleaning, Household, Lifestyle, and International. The company offers laundry additives, including bleach products under the Clorox brand, as well as Clorox 2 stain fighter and color booster; home care products primarily under the Clorox, Formula 409, Liquid-Plumr, Pine-Sol, S.O.S, and Tilex brands; naturally derived products under the Green Works brand; and professional cleaning, disinfecting, and food service products under the Clorox, Dispatch, HealthLink, Clorox Healthcare, Hidden Valley, KC Masterpiece, and Soy Vay brands.

Read More: Straddles

Get a free copy of the Zacks research report on Clorox (CLX)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.